Prothena reported financial results for the 4th quarter and full year 2024. The Company also provided business highlights and 2025 financial guidance.

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

February 20, 2025) - LiTime, a global leader in lithium iron phosphate (LFP) battery technology, has announced that its highly anticipated 2025 flagship product, the LiTime 12V 165Ah Bluetooth Lithium ...

Analog Devices will be connecting with industry leaders in Nuremberg for Embedded World 2025. Visitors to the ADI booth will ...

The UN Global Technical Regulation No. 206 on EV safety — reflected in both European and Chinese regulations — requires that ...

Quality LiFePO4 battery featuring long cycle life and smart BMS, perfect for various applications with reliable performance.

Navigation and sensing in humanoid robots involves real-time data acquisition gathered from sensors to obtain input for ...

Glory Shrivastava is a distinguished controls engineer specializing in green energy and industrial automation systems, based ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...